These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1188 related articles for article (PubMed ID: 2138003)
21. Antitumor activity of novel ailanthone derivatives in vitro and in vivo. Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149 [TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats. Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227 [TBL] [Abstract][Full Text] [Related]
23. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors. Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285 [TBL] [Abstract][Full Text] [Related]
24. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice. Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034 [TBL] [Abstract][Full Text] [Related]
25. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
26. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152). Fujimoto K; Oka T; Morimoto M Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218 [TBL] [Abstract][Full Text] [Related]
27. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611 [TBL] [Abstract][Full Text] [Related]
28. Phase I clinical investigation of 7-con-O-methylnogaril, a new anthracycline antibiotic. Dorr FA; Von Hoff DD; Kuhn JG; Schwartz R; Kisner DL Cancer Res; 1986 May; 46(5):2562-5. PubMed ID: 2938729 [TBL] [Abstract][Full Text] [Related]
29. Antileukemic activity of 4-demethoxydaunorubicin in mice. Casazza AM; Pratesi G; Giuliani F; Di Marco A Tumori; 1980 Oct; 66(5):549-64. PubMed ID: 6936969 [TBL] [Abstract][Full Text] [Related]
30. Anticancer activity of stabilized palifosfamide in vivo: schedule effects, oral bioavailability, and enhanced activity with docetaxel and doxorubicin. Jones B; Komarnitsky P; Miller GT; Amedio J; Wallner BP Anticancer Drugs; 2012 Feb; 23(2):173-84. PubMed ID: 22027537 [TBL] [Abstract][Full Text] [Related]
31. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial. Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053 [No Abstract] [Full Text] [Related]
32. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
34. Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumors. Plowman J; Harrison SD; Dykes DJ; Paull KD; Narayanan VL; Tobol HK; Martin J; Griswold DP Cancer Res; 1989 Apr; 49(8):1909-15. PubMed ID: 2702634 [TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26. Chiuten DF; Muggia FM; Johnson RK Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512 [No Abstract] [Full Text] [Related]
36. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372 [TBL] [Abstract][Full Text] [Related]
37. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days. Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244 [TBL] [Abstract][Full Text] [Related]
38. Antitumor activity of 4-demethoxydaunorubicin administered orally. Di Marco A; Casazza AM; Pratesi G Cancer Treat Rep; 1977 Aug; 61(5):893-4. PubMed ID: 890695 [No Abstract] [Full Text] [Related]
39. A phase I study of menogaril in patients with advanced cancer. Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065 [TBL] [Abstract][Full Text] [Related]